Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bergman, JM; Abrams, MT; Davide, JP; Greenberg, IB; Robinson, RG; Buser, CA; Huber, HE; Koblan, KS; Kohl, NE; Lobell, RB; Graham, SL; Hartman, GD; Williams, TM; Dinsmore, CJ
   Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   J.M. Bergman et al., "Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I", BIOORG MED, 11(11), 2001, pp. 1411-1415
2. Bohm, M; Mitsch, A; Wissner, P; Sattler, I; Schlitzer, M
   Exploration of novel aryl binding sites of farnesyltransferase using molecular modeling and benzophenone-based farnesyltransferase inhibitors
   JOURNAL OF MEDICINAL CHEMISTRY
   
   M. Bohm et al., "Exploration of novel aryl binding sites of farnesyltransferase using molecular modeling and benzophenone-based farnesyltransferase inhibitors", J MED CHEM, 44(19), 2001, pp. 3117-3124
3. Supuran, CT; Briganti, F; Mincione, G; Scozzafava, A
   Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of Clostridium histolyticum collagenase
   JOURNAL OF ENZYME INHIBITION
   
   C.T. Supuran et al., "Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of Clostridium histolyticum collagenase", J ENZ INHIB, 15(2), 2000, pp. 111-128
4. Scozzafava, A; Supuran, CT
   Protease inhibitors. Part 8: Synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties
   BIOORGANIC & MEDICINAL CHEMISTRY
   
   A. Scozzafava e C.T. Supuran, "Protease inhibitors. Part 8: Synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties", BIO MED CH, 8(3), 2000, pp. 637-645
5. Schlitzer, M; Sattler, I
   Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors
   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
   
   M. Schlitzer e I. Sattler, "Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors", EUR J MED C, 35(7-8), 2000, pp. 721-726
6. Scozzafava, A; Supuran, CT
   Protease inhibitors - Part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido- glycine hydroxamate inhibitors of Clostridium histolyticum collagenase
   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
   
   A. Scozzafava e C.T. Supuran, "Protease inhibitors - Part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido- glycine hydroxamate inhibitors of Clostridium histolyticum collagenase", EUR J MED C, 35(3), 2000, pp. 299-307
7. David, C; Bischoff, L; Roques, BP; Fournie-Zaluski, MC
   Straightforward and diastereoselective synthesis of tetrafunctionalized thiol synthons for the design of metallopeptidase inhibitors
   TETRAHEDRON
   
   C. David et al., "Straightforward and diastereoselective synthesis of tetrafunctionalized thiol synthons for the design of metallopeptidase inhibitors", TETRAHEDRON, 56(2), 2000, pp. 209-215
8. Advani, S; Roy, KB
   Properties and secondary structure analysis of BanI endonuclease: Identification of putative active site
   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
   
   S. Advani e K.B. Roy, "Properties and secondary structure analysis of BanI endonuclease: Identification of putative active site", BIOC BIOP R, 279(1), 2000, pp. 11-16
9. Okada, Y; Tsuda, Y; Tada, M; Wanaka, K; Hijikata-Okunomiya, A; Okamoto, U; Okamoto, S
   Development of plasma kallikrein selective inhibitors
   BIOPOLYMERS
   
   Y. Okada et al., "Development of plasma kallikrein selective inhibitors", BIOPOLYMERS, 51(1), 1999, pp. 41-50
10. NORCINI G; MORAZZONI G; POCCHIARI F; SANTANGELO F; SEMERARO C
    NOVEL SELECTIVE THIOL INHIBITORS OF NEUTRAL ENDOPEPTIDASE CONTAINING HETEROCYCLES AT P-2' POSITION
    Journal of enzyme inhibition
    
    G. Norcini et al., "NOVEL SELECTIVE THIOL INHIBITORS OF NEUTRAL ENDOPEPTIDASE CONTAINING HETEROCYCLES AT P-2' POSITION", Journal of enzyme inhibition, 12(2), 1997, pp. 155-160
11. SIEWINSKI M; GUTOWICZ J; ZARZYCKI A; MIKULEWICZ W
    ROLE OF CYSTEINE ENDOPEPTIDASES IN CANCEROGENESIS
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    M. Siewinski et al., "ROLE OF CYSTEINE ENDOPEPTIDASES IN CANCEROGENESIS", CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(3), 1996, pp. 169-176
12. KAWASAKI K; INOUE S; OKADA Y; IGUCHI S; OKAMOTO H
    AMINO-ACIDS AND PEPTIDES .28. PREPARATION OF POLY(ETHYLENE GLYCOL) HYBRIDS OF GLN-VAL-VAL-ALA-GLY ANALOGS AND THEIR INHIBITORY EFFECT ON PAPAIN
    Biological & pharmaceutical bulletin
    
    K. Kawasaki et al., "AMINO-ACIDS AND PEPTIDES .28. PREPARATION OF POLY(ETHYLENE GLYCOL) HYBRIDS OF GLN-VAL-VAL-ALA-GLY ANALOGS AND THEIR INHIBITORY EFFECT ON PAPAIN", Biological & pharmaceutical bulletin, 19(6), 1996, pp. 890-892
13. FINK CA; CARLSON JE; MCTAGGART PA; QIAO Y; WEBB R; CHATELAIN R; JENG AY; TRAPANI AJ
    MERCAPTOACYL DIPEPTIDES AS ORALLY-ACTIVE DUAL INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE
    Journal of medicinal chemistry
    
    C.A. Fink et al., "MERCAPTOACYL DIPEPTIDES AS ORALLY-ACTIVE DUAL INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE", Journal of medicinal chemistry, 39(16), 1996, pp. 3158-3168
14. NAGY L; KUSSTATSCHER S; HAUSCHKA PV; SZABO S
    ROLE OF CYSTEINE PROTEASES AND PROTEASE INHIBITORS IN GASTRIC-MUCOSALDAMAGE-INDUCED BY ETHANOL OR AMMONIA IN THE RAT
    The Journal of clinical investigation
    
    L. Nagy et al., "ROLE OF CYSTEINE PROTEASES AND PROTEASE INHIBITORS IN GASTRIC-MUCOSALDAMAGE-INDUCED BY ETHANOL OR AMMONIA IN THE RAT", The Journal of clinical investigation, 98(4), 1996, pp. 1047-1054
15. CALKINS CC; SLOANE BF
    MAMMALIAN CYSTEINE PROTEASE INHIBITORS - BIOCHEMICAL-PROPERTIES AND POSSIBLE ROLES IN TUMOR PROGRESSION
    Biological chemistry Hoppe-Seyler
    
    C.C. Calkins e B.F. Sloane, "MAMMALIAN CYSTEINE PROTEASE INHIBITORS - BIOCHEMICAL-PROPERTIES AND POSSIBLE ROLES IN TUMOR PROGRESSION", Biological chemistry Hoppe-Seyler, 376(2), 1995, pp. 71-80
16. MATTHEWS EK; SEATON ED; FORSYTH MJ; HUMPHREY PPA
    PHOTON PHARMACOLOGY OF AN IRON-SULFUR CLUSTER NITROSYL COMPOUND ACTING ON SMOOTH-MUSCLE
    British Journal of Pharmacology
    
    E.K. Matthews et al., "PHOTON PHARMACOLOGY OF AN IRON-SULFUR CLUSTER NITROSYL COMPOUND ACTING ON SMOOTH-MUSCLE", British Journal of Pharmacology, 113(1), 1994, pp. 87-94
17. WANG KKW; YUEN PW
    CALPAIN INHIBITION - AN OVERVIEW OF ITS THERAPEUTIC POTENTIAL
    Trends in pharmacological sciences
    
    K.K.W. Wang e P.W. Yuen, "CALPAIN INHIBITION - AN OVERVIEW OF ITS THERAPEUTIC POTENTIAL", Trends in pharmacological sciences, 15(11), 1994, pp. 412-419
18. KUNAPULI SP; COLMAN RW
    PLATELET-KININOGEN INTERACTIONS
    Platelets
    
    S.P. Kunapuli e R.W. Colman, "PLATELET-KININOGEN INTERACTIONS", Platelets, 4(2), 1993, pp. 61-65
19. BRADFORD HN; JAMESON BA; ADAM AA; WASSELL RP; COLMAN RW
    CONTIGUOUS BINDING AND INHIBITORY SITES ON KININOGENS REQUIRED FOR THE INHIBITION OF PLATELET CALPAIN
    The Journal of biological chemistry
    
    H.N. Bradford et al., "CONTIGUOUS BINDING AND INHIBITORY SITES ON KININOGENS REQUIRED FOR THE INHIBITION OF PLATELET CALPAIN", The Journal of biological chemistry, 268(35), 1993, pp. 26546-26551
20. KAKEGAWA H; NIKAWA T; TAGAMI K; KAMIOKA H; SUMITANI K; KAWATA T; DROBNICKOSOROK M; LENARCIC B; TURK V; KATUNUMA N
    PARTICIPATION OF CATHEPSIN-L ON BONE-RESORPTION
    FEBS letters
    
    H. Kakegawa et al., "PARTICIPATION OF CATHEPSIN-L ON BONE-RESORPTION", FEBS letters, 321(2-3), 1993, pp. 247-250